BV2 cells were cultivated in DMEM supplemented with 10% fetal bovine serum and 1% penicillin and streptomycin mixture in a humidified incubator with 5% CO2 at 37°C. BV2 cells were arranged to control, lipopolysaccharide (LPS), LPS+sesamol, and compound C (LPS+sesamol+compound C) groups. Cells were incubated with 10 μM sesamol dissolved in PBS for 2 h and then suffered from LPS (1 μg/mL) for 24 h to stimulate inflammation. To explore whether the AMPK pathway participates in anti-inflammation of sesamol, cells were pretreated with compound C (a specific AMPK inhibitor) for 2 h before sesamol treatment.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.